Seizure risk: who to be most careful with Case reports and safety reviews have linked L-carnitine with new-onset seizures or increased seizure frequency in some people
Given the availability of these agents for treating obesity and type 2 diabetes, along with the several agents in development, and current demand, trends in clinical practice have shifted towards personalized and tailored use of these agent for individual patient needs.6 GLP-1 and GIP agonist offer various benefits in managing obesity and type 2 diabetes
What are the symptoms of autoimmune disease
World J Gastroenterol 24(2):179194 Zhu W, Feng P-P, He K, Li S-W, Gong J-P (2018) Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet
Growth monitoring involved aseptic sampling from the culture broth at predetermined intervals (initially at 2 and 4 h, then every 30 min from 4 to 9 h, and every 2 h from 9 to 24 h), followed by serial tenfold dilutions and plating on supplemented TSA